Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23

Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23

US Patent 6673965 · Granted Jan 6, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,3-dihydrofuro[2,3-b]pyridine compounds2022
Hydroxyethylamine derivatives for the treatment of Alzheimer's disease2007
Hydroxyethylene compounds with Asp2 inhibitory activity2007
Hydroxyethylene compounds with Asp2 inhibitory activity2007
Quantitative multiplex PCR with high dynamic range2006
Benzamide derivatives, processes for their preparation, and their pharmaceutical2006
Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of2002
Compounds2001
Inhibitors of the production of S-CD23 and the secretion of TNF2001
Tryptamine analogues as 5-ht1-like agonists1997